Left ventricular remodelling in aortic stenosis

Canadian Journal of Cardiology

Volumn 30, Issue 9, 2014, Pages 1004-1011

  Rassi, Andrew N ^a   Pibarot, Philippe ^b   Elmariah, Sammy ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; AORTA VALVE REPLACEMENT; CARDIOVASCULAR PERFORMANCE; DIASTOLE; HEART VENTRICLE REMODELING; HUMAN; LEFT VENTRICULAR REMODELLING; REVIEW; SURVIVAL; SYSTOLE; TREATMENT OUTCOME;

AORTIC VALVE; AORTIC VALVE STENOSIS; HEART VENTRICLES; HUMANS; VENTRICULAR REMODELING;

EID: 84906256870     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.04.026     Document Type: Review

References (83)

1. Osnabrugge R.L., Mylotte D., Head S.J., et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. JAm Coll Cardiol 2013, 62:1002-1012.
2. Elmariah S., Mohler E.R. The pathogenesis and treatment of the valvulopathy of aortic stenosis: beyond the seas. Curr Cardiol Rep 2010, 12:125-132.
3. Ross J., Braunwald E. Aortic stenosis. Circulation 1968, 38:61-67.
4. Leon M.B., Smith C.R., Mack M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. NEngl J Med 2010, 363:1597-1607.
5. Bonow R.O., Carabello B.A., Chatterjee K. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by The Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008, 118:e523-661. 2006 Writing Committee Members, American College of Cardiology/American Heart Association Task Force et-alAmerican College of Cardiology/American Heart Association Task Force et-al.
6. Pellikka P.A., Sarano M.E., Nishimura R.A., et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005, 111:3290-3295.
7. Goldbarg S.H., Elmariah S., Miller M.A., Fuster V. Insights into degenerative aortic valve disease. JAm Coll Cardiol 2007, 50:1205-1213.
8. Sasayama S., Ross J., Franklin D., et al. Adaptations of the left ventricle to chronic pressure overload. Circ Res 1976, 38:172-178.
9. Huber D., Grimm J., Koch R., Krayenbuehl H.P. Determinants of ejection performance in aortic stenosis. Circulation 1981, 64:126-134.
10. Dweck M.R., Joshi S., Murigu T., et al. Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. JCardiovasc Magn Reson 2012, 14:50.
11. Ganau A., Devereux R.B., Roman M.J., et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. JAm Coll Cardiol 1992, 19:1550-1551.
12. Capoulade R., Clavel M.A., Dumesnil J.G., et al. Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the astronomer trial. JACC Cardiovasc Imaging 2013, 6:165-174.
13. Dumesnil J.G., Pibarot P. The obesity paradox in aortic stenosis: to be or not to be. JAm Coll Cardiol 2013, 62:1691-1693.
14. Kostkiewicz M., Tracz W., Olszowska M., Podolec P., Drop D. Left ventricular geometry and function in patients with aortic stenosis: gender differences. Int J Cardiol 1999, 71:57-61.
15. Legget M.E., Kuusisto J., Healy N.L., et al. Gender differences in left ventricular function at rest and with exercise in asymptomatic aortic stenosis. Am Heart J 1996, 131:94-100.
16. Page A., Dumesnil J.G., Clavel M.A., et al. Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin). JAm Coll Cardiol 2010, 55:1867-1874.
17. Petrov G., Regitz-Zagrosek V., Lehmkuhl E., et al. Regression of myocardial hypertrophy after aortic valve replacement: faster in women?. Circulation 2010, 122:S23-S28.
18. Lund B.P., Gohlke-Barwolf C., Cramariuc D., et al. Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy). Am J Cardiol 2010, 105:1456-1460.
19. Cacciapuoti F. Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)-possible therapeutic perspectives. JAm Soc Hypertens 2011, 5:449-455.
20. Esposito G., Rapacciuolo A., Naga Prasad S.V., et al. Genetic alterations that inhibit invivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 2002, 105:85-92.
21. Mandavia C.H., Pulakat L., DeMarco V., Sowers J.R. Over-nutrition and metabolic cardiomyopathy. Metabolism 2012, 61:1205-1210.
22. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the framingham heart study. NEngl J Med 1990, 322:1561-1566.
23. Bluemke D.A., Kronmal R.A., Lima J.A., et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. JAm Coll Cardiol 2008, 52:2148-2155.
24. Duncan A.I., Lowe B.S., Garcia M.J., et al. Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement. Ann Thorac Surg 2008, 85:2030-2039.
25. Dweck M.R., Joshi S., Murigu T., et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. JAm Coll Cardiol 2011, 58:1271-1279.
26. Hein S., Arnon E., Kostin S., et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003, 107:984-991.
27. Cioffi G., Faggiano P., Vizzardi E., et al. Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart 2011, 97:301-307.
28. Neubauer S., Horn M., Pabst T., et al. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31p-magnetic resonance spectroscopy. JInvestig Med 1997, 45:453-462.
29. Camici P.G., Crea F. Coronary microvascular dysfunction. NEngl J Med 2007, 356:830-840.
30. Rajappan K., Rimoldi O.E., Camici P.G., et al. Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Circulation 2003, 107:3170-3175.
31. Cecchi F., Sgalambro A., Baldi M., et al. Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy. JCardiovasc Transl Res 2009, 2:452-461.
32. Yarbrough W.M., Mukherjee R., Ikonomidis J.S., Zile M.R., Spinale F.G. Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications. JThorac Cardiovasc Surg 2012, 143:656-664.
33. Leone B.J., Norris R.M., Safwat A., Foex P., Ryder W.A. Effects of progressive myocardial ischaemia on systolic function, diastolic dysfunction, and load dependent relaxation. Cardiovasc Res 1992, 26:422-429.
34. Kupari M., Turto H., Lommi J. Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure?. Eur Heart J 2005, 26:1790-1796.
35. Villari B., Campbell S.E., Schneider J., et al. Sex-dependent differences in left ventricular function and structure in chronic pressure overload. Eur Heart J 1995, 16:1410-1419.
36. Hachicha Z., Dumesnil J.G., Bogaty P., Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 2007, 115:2856-2864.
37. Eleid M.F., Sorajja P., Michelena H.I., et al. Flow-gradient patterns in severe aortic stenosis with preserved ejection fraction: clinical characteristics and predictors of survival. Circulation 2013, 128:1781-1789.
38. Hachicha Z., Dumesnil J.G., Pibarot P. Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. JAm Coll Cardiol 2009, 54:1003-1011.
39. Herrmann H.C., Pibarot P., Hueter I., et al. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a placement of aortic transcatheter valves (partner) trial analysis. Circulation 2013, 127:2316-2326.
40. Herrmann S., Stork S., Niemann M., et al. Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome. JAm Coll Cardiol 2011, 58:402-412.
41. Pibarot P., Dumesnil J.G. Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction. JAm Coll Cardiol 2012, 60:1845-1853.
42. Mehrotra P., Jansen K., Flynn A.W., et al. Differential left ventricular remodelling and longitudinal function distinguishes low flow from normal-flow preserved ejection fraction low-gradient severe aortic stenosis. Eur Heart J 2013, 34:1906-1914.
43. Lee S.P., Park S.J., Kim Y.J., et al. Early detection of subclinical ventricular deterioration in aortic stenosis with cardiovascular magnetic resonance and echocardiography. JCardiovasc Magn Reson 2013, 15:72.
44. Weidemann F., Herrmann S., Stork S., et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009, 120:577-584.
45. Dahl J.S., Christensen N.L., Videbaek L., et al. Left ventricular diastolic function is associated with symptom status in severe aortic valve stenosis. Circ Cardiovasc Imaging 2014, 7:142-148.
46. Rassi A.N., Aljaroudi W., Naderi S., et al. Exercise stress echocardiography in patients with aortic stenosis: impact of baseline diastolic dysfunction and functional capacity on mortality and aortic valve replacement. Cardiovasc Diagn Ther 2013, 3:205-215.
47. Spann J.F., Bove A.A., Natarajan G., Kreulen T. Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis. Circulation 1980, 62:576-582.
48. Gerdts E., Cramariuc D., de Simone G., et al. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr 2008, 9:809-815.
49. Clavel M.A., Fuchs C., Burwash I.G., et al. Predictors of outcomes in low-flow, low-gradient aortic stenosis: results of the multicenter TOPAS study. Circulation 2008, 118:S234-S242.
50. Jander N., Minners J., Holme I., et al. Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction. Circulation 2011, 123:887-895.
51. Barasch E., Fan D., Chukwu E.O., et al. Severe isolated aortic stenosis with normal left ventricular systolic function and low transvalvular gradients: pathophysiologic and prognostic insights. JHeart Valve Dis 2008, 17:81-88.
52. Mehta R.H., Bruckman D., Das S., et al. Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery. JThorac Cardiovasc Surg 2001, 122:919-928.
53. Fuster R.G., Argudo J.A., Albarova O.G., et al. Left ventricular mass index in aortic valve surgery: a new index for early valve replacement?. Eur J Cardiothorac Surg 2003, 23:696-702.
54. Orsinelli D.A., Aurigemma G.P., Battista S., Krendel S., Gaasch W.H. Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis. A high risk subgroup identified by preoperative relative wall thickness. JAm Coll Cardiol 1993, 22:1679-1683.
55. Powell D.E., Tunick P.A., Rosenzweig B.P., et al. Aortic valve replacement in patients with aortic stenosis and severe left ventricular dysfunction. Arch Intern Med 2000, 160:1337-1341.
56. Morris J.J., Schaff H.V., Mullany C.J., et al. Determinants of survival and recovery of left ventricular function after aortic valve replacement. Ann Thorac Surg 1993, 56:22-29. discussion 29-30.
57. Halkos M.E., Chen E.P., Sarin E.L., et al. Aortic valve replacement for aortic stenosis in patients with left ventricular dysfunction. Ann Thorac Surg 2009, 88:746-751.
58. Roques F., Nashef S.A., Michel P., et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999, 15:816-822. discussion 822-3.
59. Shroyer A.L., Plomondon M.E., Grover F.L., Edwards F.H. The 1996 coronary artery bypass risk model: the Society of Thoracic Surgeons Adult Cardiac National Database. Ann Thorac Surg 1999, 67:1205-1208.
60. Pereira J.J., Lauer M.S., Bashir M., et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. JAm Coll Cardiol 2002, 39:1356-1363.
61. Tarantini G., Buja P., Scognamiglio R., et al. Aortic valve replacement in severe aortic stenosis with left ventricular dysfunction: determinants of cardiac mortality and ventricular function recovery. Eur J Cardiothorac Surg 2003, 24:879-885.
62. Pai R.G., Varadarajan P., Razzouk A. Survival benefit of aortic valve replacement in patients with severe aortic stenosis with low ejection fraction and low gradient with normal ejection fraction. Ann Thorac Surg 2008, 86:1781-1789.
63. Clavel M.A., Webb J.G., Rodes-Cabau J., et al. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation 2010, 122:1928-1936.
64. Elmariah S., Palacios I.F., McAndrew T., et al. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the placement of aortic transcatheter valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv 2013, 6:604-614.
65. Azevedo C.F., Nigri M., Higuchi M.L., et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. JAm Coll Cardiol 2010, 56:278-287.
66. Kulik A., Burwash I.G., Kapila V., Mesana T.G., Ruel M. Long-term outcomes after valve replacement for low-gradient aortic stenosis: impact of prosthesis-patient mismatch. Circulation 2006, 114:I553-I558.
67. Mohty D., Magne J., Deltreuil M., et al. Outcome and impact of surgery in paradoxical low-flow, low-gradient severe aortic stenosis and preserved left ventricular ejection fraction: a cardiac catheterization study. Circulation 2013, 128:S235-S242.
68. Le Ven F., Freeman M., Webb J., et al. Impact of low flow on the outcome of high-risk patients undergoing transcatheter aortic valve replacement. JAm Coll Cardiol 2013, 62:782-788.
69. Clavel M.A., Messika-Zeitoun D., Pibarot P., et al. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. JAm Coll Cardiol 2013, 62:2329-2338.
70. Hess O.M., Ritter M., Schneider J., Grimm J., Turina M., Krayenbuehl H.P. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation 1984, 69:855-865.
71. Krayenbuehl H.P., Hess O.M., Monrad E.S., et al. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989, 79:744-755.
72. Monrad E.S., Hess O.M., Murakami T., et al. Time course of regression of left ventricular hypertrophy after aortic valve replacement. Circulation 1988, 77:1345-1355.
73. Ikonomidis I., Tsoukas A., Parthenakis F., et al. Four year follow up of aortic valve replacement for isolated aortic stenosis: a link between reduction in pressure overload, regression of left ventricular hypertrophy, and diastolic function. Heart 2001, 86:309-316.
74. Rost C., Korder S., Wasmeier G., et al. Sequential changes in myocardial function after valve replacement for aortic stenosis by speckle tracking echocardiography. Eur J Echocardiogr 2010, 11:584-589.
75. Lamb H.J., Beyerbacht H.P., de Roos A., et al. Left ventricular remodeling early after aortic valve replacement: differential effects on diastolic function in aortic valve stenosis and aortic regurgitation. JAm Coll Cardiol 2002, 40:2182-2188.
76. Guarracino F., Talini E., Landoni G., et al. Effect of aortic valve surgery on left ventricular diastole assessed by echocardiography and neuroendocrine response: percutaneous versus surgical approach. JCardiothorac Vasc Anesth 2010, 24:25-29.
77. Ali A., Patel A., Ali Z., et al. Enhanced left ventricular mass regression after aortic valve replacement in patients with aortic stenosis is associated with improved long-term survival. JThorac Cardiovasc Surg 2011, 142:285-291.
78. Mihaljevic T., Nowicki E.R., Rajeswaran J., et al. Survival after valve replacement for aortic stenosis: implications for decision making. JThorac Cardiovasc Surg 2008, 135:1270-1278. discussion 1278-9.
79. Blais C., Dumesnil J.G., Baillot R., et al. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation 2003, 108:983-988.
80. Clavel M.A., Webb J.G., Pibarot P., et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. JAm Coll Cardiol 2009, 53:1883-1891.
81. Lund O., Emmertsen K., Dorup I., Jensen F.T., Flo C. Regression of left ventricular hypertrophy during 10 years after valve replacement for aortic stenosis is related to the preoperative risk profile. Eur Heart J 2003, 24:1437-1446.
82. Tasca G., Brunelli F., Cirillo M., et al. Impact of valve prosthesis-patient mismatch on left ventricular mass regression following aortic valve replacement. Ann Thorac Surg 2005, 79:505-510.
83. Dahl J.S., Videbaek L., Poulsen M.K., et al. Effect of candesartan treatment on left ventricular remodeling after aortic valve replacement for aortic stenosis. Am J Cardiol 2010, 106:713-719.